🔗 Share this article

This year's prestigious award in medical science has been granted for revolutionary findings that illuminate how the body's defense network targets harmful pathogens while sparing the healthy tissues.

A trio of esteemed researchers—Japan's Prof. Sakaguchi and US scientists Dr. Brunkow and Dr. Ramsdell—received this accolade.

Their research identified specialized "sentinels" within the immune system that eliminate rogue immune cells that could harming the organism.

The findings are now enabling innovative treatments for immune disorders and malignancies.

The winners will share a monetary award valued at 11m Swedish kronor.

Decisive Findings

"Their work has been decisive for understanding how the body's defenses functions and the reason we do not all suffer from serious self-attack conditions," commented the head of the Nobel Committee.

The team's research explain a core mystery: In what way does the defense system defend us from countless invaders while keeping our healthy cells unharmed?

The body's protection system employs immune cells that scan for indicators of infection, including viruses and bacteria it has not met before.

These cells employ detectors—known as receptors—that are generated randomly in a vast number of variations.

This gives the defense network the ability to combat a broad range of invaders, but the unpredictability of the mechanism inevitably creates white blood cells that can attack the body.

Security Guards of the Immune System

Researchers previously understood that some of these problematic white blood cells were destroyed in the thymus—the site where immune cells mature.

This year's award honors the identification of regulatory T-cells—known as the immune system's "peacekeepers"—which patrol the system to neutralize other defenders that assault the body's own tissues.

It is known that this process fails in self-attack conditions such as type-1 diabetes, multiple sclerosis, and RA.

The Nobel panel added, "These discoveries have established a new field of research and spurred the development of innovative treatments, for instance for cancer and immune disorders."

Regarding cancer, T-regs block the body from fighting the tumor, so studies are focused on reducing their numbers.

For self-attack disorders, trials are testing boosting T-reg cells so the body is not being harmed. A comparable method could also be useful in minimizing the chances of organ transplant rejection.

Pioneering Studies

Professor Sakaguchi, of a Japanese institution, conducted experiments on mice that had their thymus extracted, leading to self-attack conditions.

He showed that injecting defense cells from healthy animals could stop the disease—implying there was a mechanism for blocking defenders from harming the host.

Dr. Brunkow, from the Institute for Systems Biology in a US city, and Fred Ramsdell, currently at Sonoma Biotherapeutics in a California city, were studying an inherited autoimmune disease in rodents and people that resulted in the identification of a genetic factor vital for how regulatory T-cells function.

"Their groundbreaking research has uncovered how the body's defenses is kept in check by regulatory T cells, stopping it from accidentally attacking the healthy cells," commented a prominent biological science specialist.

"The work is a striking illustration of how fundamental biological research can have far-reaching consequences for public health."